Abstract
A capture immunoglobulin M (IgM) enzyme immunoassay was developed to diagnose La Crosse virus infections by the detection of specific IgM in acutephase serum specimens. IgM was detected by the capture IgM system in the serum of 24 of 29 (83%) of the patients studied. In comparison, IgM was detected in 19 of 29 (66%) of the patients by an indirect immunofluorescence technique. Specific IgM was detected in 83% (20 of 24) of patient serum specimens by day 3 after the onset of clinical symptoms.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
